Evofem Biosciences Inc (OTCPK:EVFM)
$ 0.016 0.002 (14.29%) Market Cap: 993,000.00 Enterprise Value: 43.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q2 2019 Evofem Biosciences Inc Earnings Call Transcript

Aug 06, 2019 / 03:00PM GMT
Release Date Price: $9693.7 (-4.61%)
Operator

Good day, ladies and gentleman and welcome to the Evofem Biosciences' Second Quarter 2019 Results Call.

(Operator Instructions)

I would now like to turn the call over to Amy Raskopf. You may begin.

Amy Raskopf
Evofem Biosciences, Inc. - Investor Relations

Thanks, [Michelle]. Thank you all for participating in today's call. This is Amy Raskopf, Investor Relations for Evofem Biosciences. Please note that the press release we issued yesterday after market and the presentation that accompanies this call are available in the investors section of the Evofem website at evofem.com.

With me today from the Evofem executive team are Chief Executive Officer, Saundra Pelletier; Chief Financial Officer, Jay File; Chief Medical Officer, Kelly Culwell; and Chief Commercial Officer, Russ Barrans.

As noted on slide two, I want to highlight that during this call the Evofem team will make forward-looking statements regarding the company's future expectations, plans, and prospects that constitute forward-looking statements for the purposes of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot